Covered recipient · General Payments record
MICHAEL D HARDER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,068.73
- Reported across 130 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $552.10 | 30 |
| Education | $57.80 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $192.32 | 14 |
| AIMMUNE THERAPEUTICS, INC. | $95.94 | 1 |
| PFIZER INC. | $67.55 | 4 |
| Acerta Pharma LLC | $57.80 | 1 |
| Amgen Inc. | $47.39 | 3 |
| Novo Nordisk AS | $46.38 | 3 |
| Vanda Pharmaceuticals Inc. | $38.42 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.24 | 1 |
| Merck Sharp & Dohme Corporation | $15.60 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.30 | 1 |
| Astellas Pharma US Inc | $13.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.61 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878690 | CMS |
| ABBVIE INC. | $13.52 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878692 | CMS |
| ABBVIE INC. | $10.47 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878694 | CMS |
| ABBVIE INC. | $10.90 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878696 | CMS |
| ABBVIE INC. | $9.42 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878698 | CMS |
| ABBVIE INC. | $13.69 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878700 | CMS |
| ABBVIE INC. | $11.25 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878702 | CMS |
| ABBVIE INC. | $21.96 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878704 | CMS |
| ABBVIE INC. | $13.05 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878706 | CMS |
| ABBVIE INC. | $12.08 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878708 | CMS |
| ABBVIE INC. | $18.03 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878710 | CMS |
| ABBVIE INC. | $13.74 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878712 | CMS |
| ABBVIE INC. | $8.78 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878714 | CMS |
| ABBVIE INC. | $6.82 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103878716 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $95.94 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147016503 | CMS |
| Amgen Inc. | $13.81 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117271419 | CMS |
| Amgen Inc. | $14.80 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117271421 | CMS |
| Amgen Inc. | $18.78 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115701811 | CMS |
| Astellas Pharma US Inc | $13.96 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139288902 | CMS |
| AstraZeneca Pharmaceuticals LP | $57.80 | 10/24/2024 | Education | Undisputed | 01/23/2026 | 1104470390 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.30 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101317188 | CMS |
| Merck Sharp & Dohme LLC | $15.60 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141560130 | CMS |
| Novo Nordisk Inc | $16.47 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096880066 | CMS |
| Novo Nordisk Inc | $15.19 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097749665 | CMS |
| Novo Nordisk Inc | $14.72 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096599551 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.24 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118905321 | CMS |
| PFIZER INC. | $19.35 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131325947 | CMS |
| PFIZER INC. | $14.23 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131752534 | CMS |
| PFIZER INC. | $15.90 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131972593 | CMS |
| PFIZER INC. | $18.07 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131155901 | CMS |
| Vanda Pharmaceuticals Inc. | $38.42 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133905607 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.